5.0
6 Nov 2024
Former employee, less than 1 year
Zürich
Recommend
CEO approval
Business outlook
Pros
Nice colleagues, good culture, innovative environment
Cons
The company does not grow as fast as expected due to pharma restructurations in 2024.
Check out your Company Bowl for anonymous work chats.